Results 11 to 20 of about 19,210 (233)

Central serous chorioretinopathy [PDF]

Optometry - Journal of the American Optometric Association, 2008
Central serous chorioretinopathy is a condition typically affecting young adults between 25 and 50 years of age. It is predominating in type A personality trait men. Central serous chorioretinopathy is defined clinically as a detachment of the sensory retina that is commonly unilateral but can also be bilateral.
Jeremy, Marcuson, Thomas, Riley
exaly   +9 more sources

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2020
BACKGROUND In chronic central serous chorioretinopathy (CSCR), fluid accumulates in the subretinal space. CSCR is a common visually disabling condition that develops in individuals up to 60 years of age, and there is no definitive treatment.
Andrew J Lotery, Sobha Sivaprasad, Lucy Culliford   +2 more
semanticscholar   +3 more sources

Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.

Progress in Retinal and Eye Research, 2020
Central serous chorioretinopathy (CSC) is a common form of vision loss, typically seen in working-age men. The pathophysiology behind CSC still eludes us, however significant advances have been made in understanding this disease over the last decade ...
Rebecca A. Kaye, S. Chandra, J. Sheth, C. Boon, S. Sivaprasad, A. Lotery   +5 more
semanticscholar   +3 more sources

Central serous chorioretinopathy: Towards an evidence-based treatment guideline.

Progress in Retinal and Eye Research, 2019
Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily affecting men 20-60 years of age. To date, no consensus has been reached regarding the classification of CSC, and a wide variety of interventions have been ...
Thomas J. van Rijssen, E. V. van Dijk, S. Yzer, K. Ohno-Matsui, J. Keunen, R. Schlingemann, S. Sivaprasad, G. Querques, Susan M. Downes, S. Fauser, C. Hoyng, F. C. Piccolino, Jay Chhablani, T. Lai, A. Lotery, M. Larsen, F. Holz, K. Freund, L. Yannuzzi, Camiel J. F. Boon   +19 more
semanticscholar   +3 more sources

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Progress in Retinal and Eye Research, 2015
Central serous chorioretinopathy (CSCR) is a major cause of vision threat among middle-aged male individuals. Multimodal imaging led to the description of a wide range of CSCR manifestations, and highlighted the contribution of the choroid and pigment ...
A. Daruich, A. Matet, A. Dirani, E. Bousquet, Min Zhao, N. Farman, F. Jaisser, F. Behar-Cohen   +7 more
semanticscholar   +3 more sources

Central serous chorioretinopathy: An evidence-based treatment guideline.

Progress in Retinal and Eye Research
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision loss due to macular subretinal fluid leakage and is often associated with reduced vision-related quality of life.
H. M. Feenstra, E. V. van Dijk, C M G Cheung, K. Ohno-Matsui, T. Lai, Hideki Koizumi, Michael Larsen, Giuseppe Querques, Susan M. Downes, S. Yzer, M. Breazzano, Y. Subhi, R. Tadayoni, S. Priglinger, Laurenz J. B. Pauleikhoff, C. Lange, Anat Loewenstein, R. Diederen, R. Schlingemann, C. Hoyng, Jay Chhablani, F. Holz, S. Sivaprasad, A. Lotery, L. Yannuzzi, K. B. Freund, C. Boon   +26 more
semanticscholar   +3 more sources

Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.

Ophthalmology, 2019
PURPOSE To evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC). DESIGN Retrospective, longitudinal study. PARTICIPANTS A total of 133 participants (217 eyes) with chronic CSC. METHODS A
S. Mrejen, Chandrakumar Balaratnasingam, Talia R. Kaden, Alexander R. Bottini, K. Dansingani, K. Bhavsar, Nicolas A. Yannuzzi, Samir N. Patel, Kevin C. Chen, Su-Qin Yu, G. Stoffels, R. Spaide, K. B. Freund, L. Yannuzzi   +13 more
semanticscholar   +3 more sources

Central Serous Chorioretinopathy Deteriorated With Everolimus Administration in Advanced Renal Cell Carcinoma: A Case Report. [PDF]

Case Rep Ophthalmol Med
Background Everolimus, an antineoplastic drug, is associated with various systemic adverse effects. This case report is aimed at presenting a novel ophthalmological complication, drug‐associated central serous chorioretinopathy (CSCR), following everolimus administration.
Nemati M, Niyousha M, Kharazi B, Hassanpoor N.   +3 more
europepmc   +2 more sources

A review of acute central serous chorioretinopathy [PDF]

Reviews in Clinical Medicine, 2014
Central serous chorioretinopathy is a common cause of visual morbidity. It is characterized by idiopathic serous retinal detachment in macular or paramacular regions. The symptoms of the CSC include decreased vision, micropsia and metamorphopsia.
Mirnaghi Moosavi, Mahdi Mokhtari, Masoud Shafiee   +2 more
doaj   +3 more sources

Pregnancy as a risk factor for central serous chorioretinopathy: A systematic review and meta-analysis. [PDF]

Acta Ophthalmol
Abstract Purpose Pregnancy induces significant changes in the body, including increased peripheral and choroidal blood perfusion and an increased systemic corticosteroid level. Here, we systematically reviewed the evidence on pregnancy as a risk factor for developing central serous chorioretinopathy (CSC) and conducted a meta‐analysis to obtain a ...
Eriksen NS, Fakhril-Din Z, Fasana R, Anguita R, van Dijk EHC, Ferro Desideri L, Grauslund J, Stormly Hansen M, Klefter ON, Motaabbed A, Petersen L, Ramtohul P, Sabaner MC, Savran O, Schneider M, Subhi Y.   +15 more
europepmc   +2 more sources